17.15
Toksidromlar: Klinik Özellikler
Toksidromlar, toksik maddeye maruz kalma sonucunda ortaya çıkan belirli belirti örüntüleridir. Zehirlenmenin tanı ve tedavisinde yol gösterirler. Her…
Toksidromlar, ilaç veya kimyasal aşırı doz sinyallerini gösteren belirgin semptom desenleridir. Onların tanınması hızlı teşhis ve tedaviyi mümkün kılar.
En yaygın oksidromlar antikolinergik, kolinergik, opioid, simpatitomimetik, sedatif ve hipnotiktir.
Antikolinergik oksidrom, muskarinik reseptör inhibisyonu ve parasempatik baskılamadan kaynaklanır; bu da kuru kızarmış cilt, hipertermi, midriaz, deliryum ve bağırsak hareketinin azalmasına neden olur.
Kolinerjik ajanlar asetilkolinesterazı inhibe eder, bu da asetilkolin birikimine ve muskarinik aşırı uyarıma neden olur.
Kolinerjik oksidrom uyku vakası, koma, mioz, aşırı tükürük akıntısı, ishal, mide krampları, kusma ve kas seğirmesine neden olur.
Opioid aşırı dozu MSS'yi baskılar; genellikle mioz, solunum depresyonu, bradikardi ve bağırsak hareketliliğinin azalmasına neden olur.
Sonrası, sempatik uyarımdan kaynaklanan simpatomimetik oksidrom ortaya çıkar ve bu da huzursuzluk, hipertansiyon, taşikardi, midriaz, titreme, terleme ve hipertermiye yol açar.
Sakinleştiriciler ve hipnotikler uykululuk, solunum depresyonu ve reflekslerin azalmasına neden olur.
View the full transcript and gain access to JoVE Core videos
Q1: What are toxidromes and why do healthcare providers need to recognize them?
Toxidromes are distinct symptom patterns that signal drug or chemical overdose, enabling rapid diagnosis and treatment. Recognition of these patterns is critical for healthcare providers to manage poisoning effectively and initiate appropriate pharmaceutical poisoning treatment strategies quickly.
Q2: What causes anticholinergic toxidrome and what are its clinical features?
Anticholinergic toxidrome results from muscarinic receptor inhibition and parasympathetic suppression. Clinical features include dry flushed skin, hyperthermia, mydriasis (dilated pupils), delirium, and reduced intestinal motility. Drugs like atropine and diphenhydramine commonly cause this pattern.
Q3: How does cholinergic toxidrome develop and what symptoms does it produce?
Cholinergic toxidrome occurs when agents inhibit acetylcholinesterase, causing acetylcholine accumulation and muscarinic overstimulation. Symptoms include somnolence, coma, miosis (constricted pupils), excessive salivation, diarrhea, gastric cramping, emesis, and muscle twitching. Organophosphates are a common cause.
Q4: What distinguishes sympathomimetic toxidrome from other toxidromes?
Sympathomimetic toxidrome results from sympathetic nervous system stimulation, producing agitation, hypertension, tachycardia, mydriasis, tremors, sweating, and hyperthermia. Cocaine and amphetamines commonly cause this pattern, which contrasts with depressant toxidromes that reduce vital signs.
Q5: What respiratory and cardiovascular effects characterize opioid overdose?
Opioid overdose suppresses the central nervous system, typically causing miosis, respiratory depression, bradycardia, and reduced gut motility. These effects result from opioid receptor activation and can rapidly become life-threatening if not treated promptly.
Q6: How do sedative and hypnotic toxidromes affect the central nervous system?
Sedatives and hypnotics depress central nervous system activity, causing drowsiness, respiratory depression, and diminished reflexes. Benzodiazepines and barbiturates are common examples that produce this depressant toxidrome pattern affecting multiple organ systems.
Q7: What are the six most common toxidromes encountered in clinical practice?
The six most common toxidromes are anticholinergic, cholinergic, opioid, sympathomimetic, sedative-hypnotic, and salicylate. Each produces a distinct symptom cluster reflecting the drug class's mechanism of action on the nervous system and vital functions.